SSY Group (HKSE:02005) Debt-to-EBITDA : 1.82 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is SSY Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SSY Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1,423 Mil. SSY Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1,951 Mil. SSY Group's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$1,859 Mil. SSY Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.81.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SSY Group's Debt-to-EBITDA or its related term are showing as below:

HKSE:02005' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1 Med: 1.66 Max: 2.46
Current: 1.87

During the past 13 years, the highest Debt-to-EBITDA Ratio of SSY Group was 2.46. The lowest was 1.00. And the median was 1.66.

HKSE:02005's Debt-to-EBITDA is ranked worse than
53.19% of 658 companies
in the Drug Manufacturers industry
Industry Median: 1.7 vs HKSE:02005: 1.87

SSY Group Debt-to-EBITDA Historical Data

The historical data trend for SSY Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Debt-to-EBITDA Chart

SSY Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

1.00

2.23

2.22

1.73

1.60

SSY Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															2.42	2.00	2.14	1.94	1.82

Competitive Comparison of SSY Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SSY Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SSY Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SSY Group's Debt-to-EBITDA falls into.

SSY Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SSY Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1422.761	+	1951.327)	/	2114.556
	=	1.60

SSY Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1422.761	+	1951.327)	/	1859.148
	=	1.81

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

SSY Group (HKSE:02005) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

SSY Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SSY Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

SSY Group (HKSE:02005) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG

Website

http://www.ssygroup.com.hk

SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines